Drug intelligence / Profile preview

VT-101 (The Affiliated Hospital of Xuzhou Medical University)

Development stage: Unknown
Lead developer: Wanbang Biopharmaceuticals
Modality: Oncolytic Viruses → Oncolytic Therapeutics
Administration: Intravesical

Overview

VT-101 is a recombinant oncolytic adenovirus being developed for the treatment of non-muscle invasive bladder cancer (NMIBC). Administered via intravesical instillation, the drug is designed to selectively replicate within and destroy malignant cells in the bladder lining while sparing healthy tissue. This selective replication leads to direct oncolysis and may stimulate a secondary anti-tumor immune response. The Affiliated Hospital of Xuzhou Medical University is sponsoring Phase 1/2 clinical trials to evaluate the safety, tolerability, and efficacy of VT-101 in patients with high-risk and very high-risk NMIBC.

Other names: Recombinant oncolytic adenovirus injection solution of VT-101

Beyond the preview

Go deeper on VT-101 (The Affiliated Hospital of Xuzhou Medical University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VT-101 (The Affiliated Hospital of Xuzhou Medical University).

Explore the full profile